Vascular endothelial growth factor (VEGF) and its receptors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ferrara N., 1989, Pituitary follicular cells secrete a novel heparin‐binding growth factor specific for vascular endothelial cells, Biochem. Biophys. Res. Commun., 161, 851, 10.1016/0006-291X(89)92678-8
Vaisman N., 1990, Characterization of the receptors for vascular endothelial growth factor, J. Biol. Chem., 265, 19461, 10.1016/S0021-9258(17)45395-6
Plouet J., 1990, Characterization of the receptor to vasculotropin on bovine adrenal cortex‐derived capillary endothelial cells, J. Biol. Chem., 265, 22071, 10.1016/S0021-9258(18)45668-2
Jakeman L. B., 1993, Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis, Endocrinology, 133, 848, 10.1210/endo.133.2.7688292
Barleon B., 1996, Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt‐1, Blood, 87, 3336, 10.1182/blood.V87.8.3336.bloodjournal8783336
Seetharam L., 1995, A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor (VEGF), Oncogene, 10, 135
Benjamin L. E., 1998, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the pre‐formed endothelial network and is regulated by PDGF‐B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591
Stone J., 1996, Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity, Invest. Ophthalmol. Visual Sci., 37, 290
Peer J., 1995, Hypoxia‐induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases, Lab. Invest., 72, 638
Okamoto N., 1997, Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization, Am. J. Pathol., 151, 281
Folkman J., 1998, Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence, Endocrinology, 139, 441, 10.1210/endo.139.2.5858
Roberts W. G., 1997, Neovasculature induced by vascular endothelial growth factor is fenestrated, Cancer Res., 57, 765
Dvorak H. F., 1992, Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation, Ann. N.Y. Acad. Sci., 667, 110, 10.1111/j.1749-6632.1992.tb51603.x
Rak J., 1995, Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis, Cancer Res., 55, 4575
Kieser A., 1994, Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression, Oncogene, 9, 963
Millauer B., 1996, Dominant‐negative inhibition of Flk‐1 suppresses the growth of many tumor types in vivo, Cancer Res, 56, 1615
Presta L. G., 1997, Humanization of an anti‐vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders, Cancer Res., 57, 4593
Lin P. N., 1998, Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor, Cell Growth Differ., 9, 49
Saleh M., 1996, Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence, Cancer Res., 56, 393
Ramakrishnan S., 1996, Vascular endothelial growth factor‐toxin conjugate specifically inhibits KDR/flk‐1‐positive endothelial cell proliferation in vitro and angiogenesis in vivo, Cancer Res., 56, 1324
Rockwell P., 1995, in vitro neutralization of vascular endothelial growth factor activation of FLK‐1 by a monoclonal antibody, Mol. Cell. Diff., 3, 91
Strawn L. M., 1996, Flk‐1 as a target for tumor growth inhibition, Cancer Res., 56, 3540
Tsurumi Y., 1997, Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene, Circulation, 96, 382
Deroanne C. F., 1997, Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up‐regulation of vascular endothelial growth factor expression, Cancer Res., 57, 5590
Pertovaara L., 1994, Vascular endothelial growth factor is induced in response to transforming growth factor‐beta in fibroblastic and epithelial cells, J. Biol. Chem., 269, 6271, 10.1016/S0021-9258(17)37365-9
Goad D. L., 1996, Enhanced expression of vascular endothelial growth factor in human SaOS‐2 osteoblast‐like cells and murine osteoblasts induced by insulin‐like growth factor I, Endocrinology, 137, 2262, 10.1210/endo.137.6.8641174
Dembinskakiec A., 1997, VEGF—nitric oxide reciprocal regulation, Nature Med., 3, 1177, 10.1038/nm1197-1177a
Goldberg M. A., 1994, Similarities between the oxygen‐sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin, J. Biol. Chem., 269, 4355, 10.1016/S0021-9258(17)41787-X
Jiang B. H., 1997, V‐SRC induces expression of hypoxia‐inducible factor 1 (HIF‐1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF‐1 in tumor progression, Cancer Res., 57, 5328
Damert A., 1997, Up‐regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia‐driven mechanisms, Cancer Res., 57, 3860
Stein I., 1998, Translation of vascular endothelial growth factor mRNA by internal ribosome entry : implications for translation under hypoxia, Mol. Biol. Cell, 18, 3112, 10.1128/MCB.18.6.3112
Siemeister G., 1996, Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel‐Lindau tumor suppressor protein, Cancer Res., 56, 2299
Mukhopadhyay D., 1995, Wild‐type p53 and v‐Src exert opposing influences on human vascular endothelial growth factor gene expression, Cancer Res., 55, 6161
Agani F., 1997, p53 does not repress hypoxia‐induced transcription of the vascular endothelial growth factor gene, Cancer Res., 57, 4474
Tischer E., 1991, The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing, J. Biol. Chem., 266, 11947, 10.1016/S0021-9258(18)99049-6
Houck K. A., 1992, Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms, J. Biol. Chem., 267, 26031, 10.1016/S0021-9258(18)35712-0
Gitay‐Goren H., 1992, The binding of vascular endothelial growth factor to its receptors is dependent on cell surface‐associated heparin‐like molecules, J. Biol. Chem., 267, 6093, 10.1016/S0021-9258(18)42666-X
Keyt B. A., 1996, The carboxyl‐terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency, J. Biol. Chem., 271, 7788, 10.1074/jbc.271.13.7788
Shibuya M., 1990, Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family, Oncogene, 5, 519
Jussila L., 1998, Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor‐3, Cancer Res., 58, 1599
Fournier E., 1997, Receptors for factors of the VEGF family, Bull. Cancer, 84, 397
Katoh O., 1995, Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation, Cancer Res., 55, 5687
Yang X. J., 1996, Flk‐1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells, J. Neurosci., 16, 6089, 10.1523/JNEUROSCI.16-19-06089.1996
Barleon B., 1997, Vascular endothelial growth factor up‐regulates its receptor fms‐like tyrosine kinase 1 (FLT‐1) and a soluble variant of FLT‐1 in human vascular endothelial cells, Cancer Res., 57, 5421
Waltenberger J., 1994, Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor, J. Biol. Chem., 269, 26988, 10.1016/S0021-9258(18)47116-5
Omura T., 1997, Identification of a 190‐kDa vascular endothelial growth factor 165 cell surface binding protein on a human glioma cell line, J. Biol. Chem., 272, 23317, 10.1074/jbc.272.37.23317